Male Hypogonadism Market

Global Market Study on Male Hypogonadism: North America to Remain Largest Market for Male Hypogonadism during 2017 - 2026

Male Hypogonadism Market Segmented By Testosterone Replacement Therapy, Gonadotropin Replacement Therapy in Topical Gels, Injectables, Transdermal Patches, Drug Type in Klinefelter's Syndrome, Pituitary Adenomas, Kallmann Syndrome Disease Type

Industry: Healthcare

Published Date: April-2018

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 170

Report Price

$4900*

Buy Now
Get Customisation

Report ID: PMRREP22303

Table of Content

1. Global Economic Outlook

2. Global Male Hypogonadism Market - Executive Summary

    2.1. Opportunity Analysis - Male Hypogonadism Market

3. Global Male Hypogonadism Market Overview

    3.1. Introduction

        3.1.1. Global Male Hypogonadism Market Taxonomy

        3.1.2. Global Male Hypogonadism Market Definition

    3.2. Global Male Hypogonadism Market Size (US$ Mn) and Forecast, 2012-2026

        3.2.1. Global Male Hypogonadism Market Y-o-Y Growth

    3.3. Global Male Hypogonadism Market Dynamics

    3.4. Supply Chain

    3.5. Cost Structure

    3.6. Pricing Analysis

    3.7. PESTL Analysis

    3.8. Product Life Cycle Analysis

    3.9. Epidemiology

    3.10. List of Distributors

    3.11. Key Participants Market Presence (Intensity Map) By Region

4. Global Male Hypogonadism Market Analysis and Forecast 2012-2026

    4.1. Global Male Hypogonadism Market Size and Forecast By Therapy , 2012-2026

        4.1.1. Testosterone Replacement Therapy Market Size and Forecast, 2012-2026

            4.1.1.1. Revenue (US$ Mn) Comparison, By Region

            4.1.1.2. Market Share Comparison, By Region

            4.1.1.3. Y-o-Y growth Comparison, By Region

        4.1.2. Gonadotropin Replacement Therapy Market Size and Forecast, 2012-2026

            4.1.2.1. Revenue (US$ Mn) Comparison, By Region

            4.1.2.2. Market Share Comparison, By Region

            4.1.2.3. Y-o-Y growth Comparison, By Region

    4.2. Global Male Hypogonadism Market Size and Forecast By Drug Type, 2012-2026

        4.2.1. Topical Gels Market Size and Forecast, 2012-2026

            4.2.1.1. Revenue (US$ Mn) Comparison, By Region

            4.2.1.2. Market Share Comparison, By Region

            4.2.1.3. Y-o-Y growth Comparison, By Region

        4.2.2. Injectables Market Size and Forecast, 2012-2026

            4.2.2.1. Revenue (US$ Mn) Comparison, By Region

            4.2.2.2. Market Share Comparison, By Region

            4.2.2.3. Y-o-Y growth Comparison, By Region

        4.2.3. Transdermal Patches Market Size and Forecast, 2012-2026

            4.2.3.1. Revenue (US$ Mn) Comparison, By Region

            4.2.3.2. Market Share Comparison, By Region

            4.2.3.3. Y-o-Y growth Comparison, By Region

        4.2.4. Others Market Size and Forecast, 2012-2026

            4.2.4.1. Revenue (US$ Mn) Comparison, By Region

            4.2.4.2. Market Share Comparison, By Region

            4.2.4.3. Y-o-Y growth Comparison, By Region

    4.3. Global Male Hypogonadism Market Size and Forecast By Disease Type, 2012-2026

        4.3.1. Klinefelter's Syndrome Market Size and Forecast, 2012-2026

            4.3.1.1. Revenue (US$ Mn) Comparison, By Region

            4.3.1.2. Market Share Comparison, By Region

            4.3.1.3. Y-o-Y growth Comparison, By Region

        4.3.2. Pituitary Adenomas Market Size and Forecast, 2012-2026

            4.3.2.1. Revenue (US$ Mn) Comparison, By Region

            4.3.2.2. Market Share Comparison, By Region

            4.3.2.3. Y-o-Y growth Comparison, By Region

        4.3.3. Kallmann Syndrome Market Size and Forecast, 2012-2026

            4.3.3.1. Revenue (US$ Mn) Comparison, By Region

            4.3.3.2. Market Share Comparison, By Region

            4.3.3.3. Y-o-Y growth Comparison, By Region

        4.3.4. Other Types Market Size and Forecast, 2012-2026

            4.3.4.1. Revenue (US$ Mn) Comparison, By Region

            4.3.4.2. Market Share Comparison, By Region

            4.3.4.3. Y-o-Y growth Comparison, By Region

5. North America Male Hypogonadism Market Size and Forecast, 2012-2026

    5.1. North America Outlook

    5.2. North America Parent Market Outlook

    5.3. North America Target Market Outlook

    5.4. Revenue (US$ Mn) Comparison, By Country

        5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026

        5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026

    5.5. Revenue (US$ Mn) Comparison, By Therapy

    5.6. Revenue (US$ Mn) Comparison, By Drug Type

    5.7. Revenue (US$ Mn) Comparison, By Disease Type

6. Latin America Male Hypogonadism Market Size and Forecast, 2012-2026

    6.1. Latin America Outlook

    6.2. Latin America Parent Market Outlook

    6.3. Latin America Target Market Outlook

    6.4. Revenue (US$ Mn) Comparison, By Country

        6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026

        6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026

        6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026

    6.5. Revenue (US$ Mn) Comparison, By Therapy

    6.6. Revenue (US$ Mn) Comparison, By Drug Type

    6.7. Revenue (US$ Mn) Comparison, By Disease Type

7. Europe Male Hypogonadism Market Size and Forecast, 2012-2026

    7.1. Europe Outlook

    7.2. Europe Parent Market Outlook

    7.3. Europe Target Market Outlook

    7.4. Revenue (US$ Mn) Comparison, By Country

        7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026

        7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026

        7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026

        7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026

        7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026

        7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026

    7.5. Revenue (US$ Mn) Comparison, By Therapy

    7.6. Revenue (US$ Mn) Comparison, By Drug Type

    7.7. Revenue (US$ Mn) Comparison, By Disease Type

8. Japan Male Hypogonadism Market Size and Forecast, 2012-2026

    8.1. Japan Outlook

    8.2. Japan Parent Market Outlook

    8.3. Japan Target Market Outlook

    8.4. Revenue (US$ Mn), 2012-2026

        8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026

    8.5. Revenue (US$ Mn) Comparison, By Therapy

    8.6. Revenue (US$ Mn) Comparison, By Drug Type

    8.7. Revenue (US$ Mn) Comparison, By Disease Type

9. APEJ Male Hypogonadism Market Size and Forecast, 2012-2026

    9.1. APEJ Outlook

    9.2. APEJ Parent Market Outlook

    9.3. APEJ Target Market Outlook

    9.4. Revenue (US$ Mn) Comparison, By Country

        9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026

        9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026

        9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026

        9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026

        9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026

        9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026

    9.5. Revenue (US$ Mn) Comparison, By Therapy

    9.6. Revenue (US$ Mn) Comparison, By Drug Type

    9.7. Revenue (US$ Mn) Comparison, By Disease Type

10. MEA Male Hypogonadism Market Size and Forecast, 2012-2026

    10.1. MEA Outlook

    10.2. MEA Parent Market Outlook

    10.3. MEA Target Market Outlook

    10.4. Revenue (US$ Mn) Comparison, By Country

        10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026

        10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026

        10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026

        10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026

    10.5. Revenue (US$ Mn) Comparison, By Therapy

    10.6. Revenue (US$ Mn) Comparison, By Drug Type

    10.7. Revenue (US$ Mn) Comparison, By Disease Type

11. Global Male Hypogonadism Market Company Share, Competition Landscape and Company Profiles

    11.1. Company Share Analysis

    11.2. Competition Landscape

    11.3. Company Profiles

        11.3.1. Endo International Plc

        11.3.2. Eli Lilly and Company Ltd.

        11.3.3. AbbVie, Inc.

        11.3.4. Pfizer, Inc.

        11.3.5. Merck KGaA

        11.3.6. Allergan Plc

        11.3.7. Sun Pharmaceutical Industries Limited

        11.3.8. Ferring B.V.

    11.4. Key takeaways - Male Hypogonadism Market

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

List Of Table

TABLE 1: Global Male Hypogonadism Market Value (US$ Mn), 2012-2017

TABLE 2: Global Male Hypogonadism Market Value (US$ Mn), 2018-2026

TABLE 3: Global Male Hypogonadism Market Value (US$ Mn) and Y-o-Y, 2017-2026

TABLE 4: Global Testosterone Replacement Therapy Segment Value (US$ Mn), By Region 2012-2017

TABLE 5: Global Testosterone Replacement Therapy Segment Value (US$ Mn), By Region 2018-2026

TABLE 6: Global Testosterone Replacement Therapy Segment Market Share, By Region 2012-2017

TABLE 7: Global Testosterone Replacement Therapy Segment Market Share, By Region 2018-2026

TABLE 8: Global Testosterone Replacement Therapy Segment Y-o-Y, By Region 2017-2026

TABLE 9: Global Gonadotropin Replacement Therapy Segment Value (US$ Mn), By Region 2012-2017

TABLE 10: Global Gonadotropin Replacement Therapy Segment Value (US$ Mn), By Region 2018-2026

TABLE 11: Global Gonadotropin Replacement Therapy Segment Market Share, By Region 2012-2017

TABLE 12: Global Gonadotropin Replacement Therapy Segment Market Share, By Region 2018-2026

TABLE 13: Global Gonadotropin Replacement Therapy Segment Y-o-Y, By Region 2017-2026

TABLE 14: Global Topical Gels Segment Value (US$ Mn), By Region 2012-2017

TABLE 15: Global Topical Gels Segment Value (US$ Mn), By Region 2018-2026

TABLE 16: Global Topical Gels Segment Market Share, By Region 2012-2017

TABLE 17: Global Topical Gels Segment Market Share, By Region 2018-2026

TABLE 18: Global Topical Gels Segment Y-o-Y, By Region 2017-2026

TABLE 19: Global Injectables Segment Value (US$ Mn), By Region 2012-2017

TABLE 20: Global Injectables Segment Value (US$ Mn), By Region 2018-2026

TABLE 21: Global Injectables Segment Market Share, By Region 2012-2017

TABLE 22: Global Injectables Segment Market Share, By Region 2018-2026

TABLE 23: Global Injectables Segment Y-o-Y, By Region 2017-2026

TABLE 24: Global Transdermal Patches Segment Value (US$ Mn), By Region 2012-2017

TABLE 25: Global Transdermal Patches Segment Value (US$ Mn), By Region 2018-2026

TABLE 26: Global Transdermal Patches Segment Market Share, By Region 2012-2017

TABLE 27: Global Transdermal Patches Segment Market Share, By Region 2018-2026

TABLE 28: Global Transdermal Patches Segment Y-o-Y, By Region 2017-2026

TABLE 29: Global Others Segment Value (US$ Mn), By Region 2012-2017

TABLE 30: Global Others Segment Value (US$ Mn), By Region 2018-2026

TABLE 31: Global Others Segment Market Share, By Region 2012-2017

TABLE 32: Global Others Segment Market Share, By Region 2018-2026

TABLE 33: Global Others Segment Y-o-Y, By Region 2017-2026

TABLE 34: Global Klinefelter's Syndrome Segment Value (US$ Mn), By Region 2012-2017

TABLE 35: Global Klinefelter's Syndrome Segment Value (US$ Mn), By Region 2018-2026

TABLE 36: Global Klinefelter's Syndrome Segment Market Share, By Region 2012-2017

TABLE 37: Global Klinefelter's Syndrome Segment Market Share, By Region 2018-2026

TABLE 38: Global Klinefelter's Syndrome Segment Y-o-Y, By Region 2017-2026

TABLE 39: Global Pituitary Adenomas Segment Value (US$ Mn), By Region 2012-2017

TABLE 40: Global Pituitary Adenomas Segment Value (US$ Mn), By Region 2018-2026

TABLE 41: Global Pituitary Adenomas Segment Market Share, By Region 2012-2017

TABLE 42: Global Pituitary Adenomas Segment Market Share, By Region 2018-2026

TABLE 43: Global Pituitary Adenomas Segment Y-o-Y, By Region 2017-2026

TABLE 44: Global Kallmann Syndrome Segment Value (US$ Mn), By Region 2012-2017

TABLE 45: Global Kallmann Syndrome Segment Value (US$ Mn), By Region 2018-2026

TABLE 46: Global Kallmann Syndrome Segment Market Share, By Region 2012-2017

TABLE 47: Global Kallmann Syndrome Segment Market Share, By Region 2018-2026

TABLE 48: Global Kallmann Syndrome Segment Y-o-Y, By Region 2017-2026

TABLE 49: Global Other Types Segment Value (US$ Mn), By Region 2012-2017

TABLE 50: Global Other Types Segment Value (US$ Mn), By Region 2018-2026

TABLE 51: Global Other Types Segment Market Share, By Region 2012-2017

TABLE 52: Global Other Types Segment Market Share, By Region 2018-2026

TABLE 53: Global Other Types Segment Y-o-Y, By Region 2017-2026

TABLE 54: North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 55: North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 56: North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 57: North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 58: North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 59: North America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

TABLE 60: North America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

TABLE 61: North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

TABLE 62: North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

TABLE 63: North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 64: North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 65: North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

TABLE 66: North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

TABLE 67: Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 68: Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 69: Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 70: Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 71: Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 72: Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

TABLE 73: Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

TABLE 74: Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

TABLE 75: Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

TABLE 76: Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 77: Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 78: Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

TABLE 79: Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

TABLE 80: Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 81: Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 82: Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 83: Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 84: Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 85: Europe Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

TABLE 86: Europe Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

TABLE 87: Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

TABLE 88: Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

TABLE 89: Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 90: Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 91: Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

TABLE 92: Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

TABLE 93: Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 94: Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 95: Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 96: Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 97: Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 98: Japan Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

TABLE 99: Japan Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

TABLE 100: Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

TABLE 101: Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

TABLE 102: Japan Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 103: Japan Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 104: Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

TABLE 105: Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

TABLE 106: APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 107: APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 108: APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 109: APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 110: APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 111: APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

TABLE 112: APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

TABLE 113: APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

TABLE 114: APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

TABLE 115: APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 116: APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 117: APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

TABLE 118: APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

TABLE 119: MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 120: MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 121: MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 122: MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 123: MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 124: MEA Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

TABLE 125: MEA Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

TABLE 126: MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

TABLE 127: MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

TABLE 128: MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 129: MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 130: MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

TABLE 131: MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

FIG. 1: Global Male Hypogonadism Market Value (US$ Mn), 2012-2017

FIG. 2: Global Male Hypogonadism Market Value (US$ Mn) Forecast, 2018-2026

FIG. 3: Global Male Hypogonadism Market Value (US$ Mn) and Y-o-Y, 2017-2026

FIG. 4: Global Testosterone Replacement Therapy Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 5: Global Testosterone Replacement Therapy Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 6: Global Testosterone Replacement Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 7: Global Gonadotropin Replacement Therapy Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 8: Global Gonadotropin Replacement Therapy Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 9: Global Gonadotropin Replacement Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 10: Global Topical Gels Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 11: Global Topical Gels Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 12: Global Topical Gels Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 13: Global Injectables Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 14: Global Injectables Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 15: Global Injectables Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 16: Global Transdermal Patches Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 17: Global Transdermal Patches Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 18: Global Transdermal Patches Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 19: Global Others Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 20: Global Others Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 21: Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 22: Global Klinefelter's Syndrome Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 23: Global Klinefelter's Syndrome Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 24: Global Klinefelter's Syndrome Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 25: Global Pituitary Adenomas Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 26: Global Pituitary Adenomas Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 27: Global Pituitary Adenomas Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 28: Global Kallmann Syndrome Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 29: Global Kallmann Syndrome Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 30: Global Kallmann Syndrome Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 31: Global Other Types Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 32: Global Other Types Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 33: Global Other Types Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 34: North America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

FIG. 35: North America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

FIG. 36: North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

FIG. 37: North America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

FIG. 38: North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017

FIG. 39: North America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 40: North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

FIG. 41: North America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

FIG. 42: Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

FIG. 43: Latin America Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

FIG. 44: Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

FIG. 45: Latin America Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

FIG. 46: Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017

FIG. 47: Latin America Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 48: Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

FIG. 49: Latin America Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

FIG. 50: Europe Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

FIG. 51: Europe Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

FIG. 52: Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

FIG. 53: Europe Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

FIG. 54: Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017

FIG. 55: Europe Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 56: Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

FIG. 57: Europe Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

FIG. 58: Japan Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

FIG. 59: Japan Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

FIG. 60: Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

FIG. 61: Japan Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

FIG. 62: Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

FIG. 63: Japan Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 64: Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

FIG. 65: Japan Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

FIG. 66: APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

FIG. 67: APEJ Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

FIG. 68: APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

FIG. 69: APEJ Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

FIG. 70: APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017

FIG. 71: APEJ Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 72: APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

FIG. 73: APEJ Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

FIG. 74: MEA Male Hypogonadism Market Value (US$ Mn), By Country 2012-2017

FIG. 75: MEA Male Hypogonadism Market Value (US$ Mn), By Country 2018-2026

FIG. 76: MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2012-2017

FIG. 77: MEA Male Hypogonadism Market Value (US$ Mn), By Therapy 2018-2026

FIG. 78: MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2012-2017

FIG. 79: MEA Male Hypogonadism Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 80: MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2012-2017

FIG. 81: MEA Male Hypogonadism Market Value (US$ Mn), By Disease Type 2018-2026

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate